HK1057331A1 - Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives - Google Patents

Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives

Info

Publication number
HK1057331A1
HK1057331A1 HK03108333A HK03108333A HK1057331A1 HK 1057331 A1 HK1057331 A1 HK 1057331A1 HK 03108333 A HK03108333 A HK 03108333A HK 03108333 A HK03108333 A HK 03108333A HK 1057331 A1 HK1057331 A1 HK 1057331A1
Authority
HK
Hong Kong
Prior art keywords
angiogenesis
treatment
acid derivatives
related disorders
phenylacetic acid
Prior art date
Application number
HK03108333A
Other languages
English (en)
Inventor
Michael A Kapin
David P Bingaman
Daniel A Gamache
Gustav Graff
John M Yanni
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of HK1057331A1 publication Critical patent/HK1057331A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03108333A 2000-08-14 2003-11-14 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives HK1057331A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22513300P 2000-08-14 2000-08-14
PCT/US2001/025318 WO2002013804A2 (en) 2000-08-14 2001-08-13 Method of treating angiogenesis-related disorders using benzoyl phenylacetic acid

Publications (1)

Publication Number Publication Date
HK1057331A1 true HK1057331A1 (en) 2004-04-02

Family

ID=22843668

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108333A HK1057331A1 (en) 2000-08-14 2003-11-14 Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives

Country Status (19)

Country Link
US (1) US20020037929A1 (es)
EP (1) EP1309323B1 (es)
JP (2) JP5586117B2 (es)
KR (1) KR20030017653A (es)
CN (1) CN1447688A (es)
AR (1) AR030345A1 (es)
AT (1) ATE345123T1 (es)
AU (2) AU2001283337B2 (es)
BR (1) BR0113204A (es)
CA (1) CA2417282C (es)
DE (1) DE60124560T2 (es)
DK (1) DK1309323T3 (es)
ES (1) ES2275710T3 (es)
HK (1) HK1057331A1 (es)
MX (1) MXPA03001057A (es)
PL (1) PL366220A1 (es)
PT (1) PT1309323E (es)
WO (1) WO2002013804A2 (es)
ZA (1) ZA200300782B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649575A (zh) * 2002-05-03 2005-08-03 爱尔康公司 用氨芬酸或奈帕芬胺治疗血管内皮生长因子介导的血管疾病的方法
CN1681510A (zh) * 2002-09-16 2005-10-12 爱尔康制造有限公司 Pde ⅳ抑制剂治疗血管生成的用途
JP2006512318A (ja) * 2002-11-12 2006-04-13 アルコン，インコーポレイテッド 眼の血管新生もしくは水腫状の疾患および障害を処置するためのヒストンデアセチラーゼインヒビター
EP1586316B1 (en) 2003-01-21 2008-04-30 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
BRPI0517972A (pt) * 2004-11-09 2008-10-21 Alcon Inc ácido 5,6,7-triidroxiheptanóico e análogos para o tratamento de doenças oculares e doenças associadas com respostas hiperproliferativas e angiogênicas
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
FR2909876A1 (fr) * 2006-12-19 2008-06-20 Galderma Res & Dev S N C Snc Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques
WO2009073138A2 (en) * 2007-11-30 2009-06-11 Ampla Pharmaceuticals Inc. Treatment of metabolic syndrome with novel amides
WO2009105534A2 (en) * 2008-02-21 2009-08-27 Ista Pharmaceuticals Ophthalmic nsaids as adjuvants
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
US9630909B2 (en) 2013-06-27 2017-04-25 Mylan Laboratories Ltd Process for the preparation of nepafenac

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH577461A5 (es) * 1975-08-13 1976-07-15 Robins Co Inc A H
ZA805476B (en) * 1979-09-26 1981-11-25 Robins Co Inc A H 2-amino-3-benzoyl-phenylacetamides and cyclic homologues
US4313949A (en) * 1979-09-26 1982-02-02 A. H. Robins Company, Inc. Method of producing an inhibitory effect on blood platelet aggregation
US4254146A (en) * 1979-10-18 1981-03-03 A. H. Robins Company, Inc. 3-Benzoyl-2-nitrophenylacetic acids, metal salts, amides and esters
IL61945A (en) * 1980-02-19 1984-09-30 Robins Co Inc A H 2-amino-3-(hydroxy(phenyl)methyl)phenylacetic acids,esters and amides and pharmaceutical compositions containing them
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4503073A (en) * 1981-01-07 1985-03-05 A. H. Robins Company, Incorporated 2-Amino-3-(alkylthiobenzoyl)-phenylacetic acids
IL64724A0 (en) * 1981-02-17 1982-03-31 Robins Co Inc A H 2-amino-3-(halobenzoyl)-methylphenylacetic acids and esters and salts thereof and pharmaceutical compositions containing them
US4568695A (en) * 1983-12-07 1986-02-04 A. H. Robins Company, Incorporated 2-Amino-3-benzoyl-phenethylalcohols and intermediates therefor
US4683242A (en) * 1985-10-28 1987-07-28 A. H. Robins Company, Incorporated Transdermal treatment for pain and inflammation with 2-amino-3-aroylbenzeneacetic acids, salts and esters
CA1325382C (en) * 1988-01-27 1993-12-21 Takahiro Ogawa Locally administrable therapeutic composition for inflammatory disease
US5475034A (en) * 1994-06-06 1995-12-12 Alcon Laboratories, Inc. Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6066671A (en) * 1997-12-19 2000-05-23 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use
US6207700B1 (en) * 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
PT1221917E (pt) * 1999-10-21 2005-04-29 Alcon Inc Dispositivo para ministrar medicamentos
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
WO2001035181A1 (en) * 1999-11-11 2001-05-17 Wireless Methods Ltd. Remote switching and actuation of electrical devices

Also Published As

Publication number Publication date
CA2417282A1 (en) 2002-02-21
WO2002013804A3 (en) 2002-06-06
DE60124560T2 (de) 2007-09-06
DE60124560D1 (de) 2006-12-28
AU2001283337B2 (en) 2006-06-15
WO2002013804A2 (en) 2002-02-21
PL366220A1 (en) 2005-01-24
AR030345A1 (es) 2003-08-20
ATE345123T1 (de) 2006-12-15
US20020037929A1 (en) 2002-03-28
BR0113204A (pt) 2006-02-21
ZA200300782B (en) 2004-08-27
JP5586117B2 (ja) 2014-09-10
PT1309323E (pt) 2007-01-31
EP1309323B1 (en) 2006-11-15
AU8333701A (en) 2002-02-25
DK1309323T3 (da) 2007-03-19
MXPA03001057A (es) 2004-09-10
EP1309323A2 (en) 2003-05-14
JP2012193214A (ja) 2012-10-11
KR20030017653A (ko) 2003-03-03
CA2417282C (en) 2009-12-22
ES2275710T3 (es) 2007-06-16
JP2004520267A (ja) 2004-07-08
CN1447688A (zh) 2003-10-08

Similar Documents

Publication Publication Date Title
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GB0007193D0 (en) Treatment of movrmrnt disorders
IL162533A0 (en) Chalcone derivatives and their use to treat diseases
AU2001249329A1 (en) Lipoxin analogs and methods for the treatment of periodontal disease
HUP0102295A3 (en) Benzamide derivatives for the treatment of diseases mediated by cytokines
GB0013378D0 (en) Use of therapeutic benzamide derivatives
PL357780A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
ITMI20001705A0 (it) Procedimento per la denitrificazione delle acque
HK1057331A1 (en) Treatment of angiogenesis-related disorders using benzoyl phenylacetic acid derivatives
NO20030295D0 (no) Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser
HK1059080A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl- acetic acid and the use thereof for treating migraines and pain
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
IL155874A0 (en) Treatment of anxiety disorders
AU2001251306A1 (en) Treatment of sleep disorders with hypocretin-1
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
GB0028484D0 (en) Imidazolone derivatives for the treatment of viral diseases
SG107315A1 (en) Use of conjugated linoleic acid derivatives
SI1282616T1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain
TW483328U (en) Wheelchair capable of assisting standing
GB0023071D0 (en) Treatment of inflammatory skin conditions
GB0003228D0 (en) Treatment of GI disorders
GB0017951D0 (en) Treatment of movement disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170813